The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours

---

Copy For Citation

YILMAZ B., Erdem D., Teker F., Gören İ., YILDIRIM B., Kut E., ...More

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol.44, no.3, pp.627-638, 2016 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 44 Issue: 3
• Publication Date: 2016
• Doi Number: 10.1177/0300060516638992
• Journal Name: JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.627-638
• Keywords: Hepatitis B virus reactivation, hepatitis B surface antibody, chemotherapy, solid tumour, haematological malignancy, VIRUS HBV REACTIVATION, BREAST-CANCER PATIENTS, RECEIVING CYTOTOXIC CHEMOTHERAPY, LYMPHOMA PATIENTS, RISK-FACTORS, POSITIVE PATIENTS, CELL LYMPHOMA, LAMIVUDINE, INFECTION, METAANALYSIS
• Ondokuz Mayıs University Affiliated: Yes

Abstract

Objective To investigate the effect of immunosuppressive anticancer therapy on titre levels of anti-hepatitis B surface antibodies (anti-HBs) in hepatitis B surface antigen (HBsAg) negative and anti-HBs positive patients with haematological malignancies or solid tumours.